Steve Jang brings his expertise in causal inference and econometric analysis with real-world data to ATI Advisory. Before joining ATI, Steve was a Quantitative Scientist with Verily Life Sciences, the healthcare division of Alphabet Inc. He was responsible for evaluating Verily’s chronic disease management products and conducted additional health outcomes research using claims data, electronic health records, and geo-spatial data. Prior to Verily, Jang was a Senior Provider Informatics Analyst for Blue Cross Blue Shield of Massachusetts where he translated findings from claims data into interventions to reduce healthcare costs and improve quality of care across healthcare systems in the Commonwealth. Jang received an MPH in epidemiology and health care policy from Boston University School of Public Health and holds a bachelor's degree in microbiology and immunology from the University of British Columbia.